Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date07 Nov 2019 |
100 Clinical Results associated with Giskit Pharma B.V.
0 Patents (Medical) associated with Giskit Pharma B.V.
100 Deals associated with Giskit Pharma B.V.
100 Translational Medicine associated with Giskit Pharma B.V.